Specialty	Psychology-PhD
Clinical Interests	Child Psychiatry
	Neuropsychiatry
Gender	Female
E-mail	mary.solanto@mssm.edu
Education and Training	PHD, S.U.N.Y., Buffalo
	Fellowship, Child Mental Health, Albert Einstein College of Medicine
Awards	Elaine Schlosser Lewis Award for Research in ADHD American Academy of Child and Adolescent Psychiatry
	James A. Shannon Award National Institute of Child Health and Human Development
	Summer Research Grant Award SUNY Buffalo
	Cum Laude Princeton University
	Matthew Vassar Scholar
	Milton Rosenbaum Research Award, first place Department of Psychiatry, Albert Einstein College of Medicine

Dr. Solanto is the Director of the Attention-Deficit/Hyperactivity Disorder Center.

Dr. Mary Solanto received her undergraduate degree in psychology at Princeton University, a Masters degree in neurobiology from Cornell Medical School, and her Ph.D. in Clinical Psychology from SUNY at Buffalo. She interned in clinical child psychology at Case Western Reserve Medical School and completed a postdoctoral fellowship at the Albert Einstein College of Medicine. She was Assistant Professor, and later Associate Professor, in the Division of Behavioral Pediatrics, Department of Pediatrics at Albert Einstein College of Medicine.

Currently, Dr. Solanto is Associate Professor of Psychiatry and Director of the AD/HD Center in the Division of Child and Adolescent Psychiatry of the Department of Psychiatry at Mount Sinai School of Medicine. Her research on the cognitive and behavioral functioning of children with AD/HD and the effects of psychostimulants has been supported by grants from the National Institute of Mental Health and the National Institute of Child Health and Human Development. She is active in the training of child psychiatrists and psychologists in the diagnosis, causes, and treatment of AD/HD and related disorders, and frequently conducts workshops with parent and teacher groups concerning identification and treatment of children with AD/HD. She has published numerous scholarly papers concerning AD/HD and is a frequent reviewer for professional journals. She is a member of the editorial board of the Journal of Attention Disorders. She recently edited a book (with Amy Arnsten and Xavier Castellanos) titled Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (Oxford University Press).

In the News

Dr. Solanto discusses a new Attention Disorder study in The Daily News feature The Daily Check Up. View the PDF.

Education and Training	PHD, S.U.N.Y., Buffalo
	Fellowship, Child Mental Health, Albert Einstein College of Medicine

Specialty	Psychology-PhD
Clinical Interests	Child Psychiatry
	Neuropsychiatry

Dr. Solanto's research has been supported by grants from the National Institute of Mental Health, the National Institute of Child Health and Human Development, and the National Institute on Neurological Diseases and Stroke. Her interests include:

•  Neuropsychological functioning in children and adults with ADHD
• Time-action and dose-response effects of methylphenidate (Ritalin) on behavior and psychophysiology
•  Effects of stimulant medications on cognitive and behavioral functioning
• Neurobiological mechanisms of action of stimulants
• Effects of reinforcement (reward) in children with ADHD
• Differentiating Combined and Predominantly Inattentive subtypes of ADHD
• Diagnosis of ADHD in adults
• Psychosocial interventions for adults with ADHD

Solanto MV, Pope-Boyd S, Tryon W, Stepak B. Social functioning in Predominantly Inattentive and Combined subtypes of children with ADHD. Journal of Attention Disorders;.

Solanto MV, Schulz KP, Fin J, Tang CY, Newcorn JH. Event-related fMRI of inhibitory control in the Predominantly Inattentive and Combined subtypes of AD/HD. Journal of Neuroimaging;.

Scahill L, Solanto MV, McGuire J. The science and ethics of placebo use in pediatric psychopharmacology. Ethics and Behavior 2008; 18(2-3): 266-285.

Weiss M, Safren SA, Solanto MV, Hechtman L, Rostain AL, Ramsay JR, Murray C. Research forum on psychological treatment of adults with ADHD. Journal of Attention Disorders 2008; 11(6): 642-651.

Solanto MV, Schachar R, Ickowicz A. The Psychopharmacology of ADHD. In: Fitzgerald M, Bellgrove MA, Gill M, editors. Handbook of Attention Deficit Hyperactivity Disorder. West Sussex, England, John Wiley & Sons, Ltd; pp269-314.

Solanto MV, Etefia K, Marks DJ. The utility of self-report measures and the Continuous Performance Test in the diagnosis of AD/HD in adults. CNS Spectrums 2004; 9: 649-659.

Solanto MV. Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research . Behavioural Brain Research 2002; 130: 65-71.

Solanto MV, Arnsten A, Castellanos FX, editors. Stimulant Drugs and AD/HD: Basic and Clinical Neuroscience. New York, Oxford University Press;.

Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan G, Wigal T, Hechtman L, Hinshaw S, Pollock S, Terkel E. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH Multi-Modal Treatment Study of AD/HD. J Abnorm Child Psychol 2001; 29: 215-228.

Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit/hyperactivity disorder: A review and integration. Behav Brain Res 1998; 94: 127-152.